Low levels of testosterone, hypogonadism, have several common features with the metabolic syndrome. In the Tromsø Study, a population-based health survey, testosterone levels were inversely associated with anthropometrical measurements, and the lowest levels of total and free testosterone were found in men with the most pronounced central obesity. Total testosterone was inversely associated with systolic blood pressure, and men with hypertension had lower levels of both total and free testosterone. Furthermore, men with diabetes had lower testosterone levels compared to men without a history of diabetes, and an inverse association between testosterone levels and glycosylated hemoglobin was found. Thus, there are strong associations between low levels of testosterone and the different components of the metabolic syndrome. In addition, an independent association between low testosterone levels and the metabolic syndrome itself has recently been presented in both cross-sectional and prospective population-based studies. Thus, testosterone may have a protective role in the development of metabolic syndrome and subsequent diabetes mellitus and cardiovascular disease in aging men. However, clinical trials are needed to confirm this assumption.
Introduction
Hypogonadism in men have several common features with the metabolic syndrome such as disturbances in glucose metabolism and insulin secretion, overweight and abdominal fat distribution. Owing to these similarities and the relationship between the metabolic syndrome and cardiovascular disease (CVD), there has recently been an increasing focus on the relationship between testosterone and the metabolic syndrome in men. This paper is based on a talk at the Fifth World Congress of the Ageing Male, Salzburg, Austria, 2006, where epidemiological data supporting these associations were presented with a special reference to the results from the Tromsø Study in North Norway.
The Tromsø Study is a population-based health survey that was started in 1974 with a main focus on CVD. In the fourth study in 1994-1995, sex hormones were available in a random sample of 1565 men 25-84 years old. From this large database, we have published several papers 1-5 on the association between endogenous testosterone and components of the metabolic syndrome, which are of course also risk factors for CVD.
The metabolic syndrome
The metabolic syndrome includes a clustering of metabolic derangements with an increasing risk for developing diabetes and CVD in affected subjects. There are at least four different definitions for the metabolic syndrome: the World Health Organization (WHO), 6 the National Cholesterol Education Program's Adult Treatment Panel (NCEP), 7 the position statement of the American College of Endocrinology on Insulin Resistance Syndrome 8 and the International Diabetes Federation proposal. 9 Clearly, the lack of a standard definition makes comparison between studies difficult, and accordingly estimates of the prevalence of the metabolic syndrome differ (24.2-27.9%, in a recent publication). 10 However, studies that have compared WHO and the NCEP definitions ( Table 1 ) have reported that both definitions will identify persons at risk for diabetes, CVD and all-cause mortality.
Associations between testosterone and components of the metabolic syndrome
Testosterone and abdominal obesity Endogenous testosterone levels have been found to be inversely associated with anthropometrical measurements in several epidemiological studies.
2, [13] [14] [15] However, only three population-based studies had as a main object to investigate the associations between testosterone and body fat distribution. 2, 14, 15 In the Tromsø population, we found that total and free testosterone was inversely associated with body mass index (BMI) and waist circumference (WC).
1,2
In age-adjusted analyses, men with WC 4102 cm had significantly lower testosterone levels compared to men with normal WC (11.0 vs 14.7 nmol/l; Po0.001) (Figure 1 ). These associations remained significant also after adjustment for BMI as a surrogate for overall body fatness. 2 We also explored the combined influence of BMI and WC on the levels of total and free testosterone (Figure 2 ). The lowest levels of both total and free testosterone were found in men with a WC in the highest tertile who at the same time had a BMI in the lowest tertile -men with the most pronounced abdominal obesity.
2 Our results are supported by a publication from the San Antonio Hearth Study where free testosterone was inversely associated with conicity index (an index of central adiposity) in a subset of 178 men. 14 Furthermore, Khaw and Barrett-Connor 15 reported that in a cohort of 511 men participating in the Rancho Bernardo Study, levels of total testosterone measured at baseline were inversely related to subsequent central adiposity, estimated 12 years later using the waist-to-hip ratio (WHR).
Tromsø is located at 701 north with extreme variation in daylight exposure -the sun is below the horizon from November 23 to January 21 and does not set from May 23 to July 23. As the fourth Tromsø Study ran through a year, we therefore had the opportunity to evaluate seasonal variation of testosterone. We found that testosterone had a seasonal bimodal distribution, with the lowest levels in summer, a small peak in the late winter and a higher more prominent peak in the fall. 3 We hypothesized that this variation in total testosterone could be owing to seasonal changes in weight, and indeed we found a strong seasonal variation in WHR. This seasonal variation in WHR was inversely associated with total testosterone levels, as shown in Figure 3a . Furthermore, by inverting the axis of WHR, as shown in Figure 3b , the close relationship between testosterone levels and abdominal obesity was even more apparent. 
Testosterone and lipids
Most but not all cross-sectional studies have reported a positive association between endogenous testosterone and high-density lipoprotein (HDL) cholesterol in adult men. [16] [17] [18] High testosterone levels have been found associated with low triglyceride levels in both cross-sectional 16 and longitudinal 19 studies, and a decrease in endogenous testosterone was associated with an increase in triglycerides. 19 Thus, higher endogenous testosterone levels in men are associated with a more favorable lipid profile.
Testosterone and blood pressure In the Tromsø Study, higher total testosterone levels were associated with lower systolic blood pressure and normotensive men had higher levels of both total and free testosterone (14.0 vs 12.4 nmol/l; Po0.001 and 210 vs 201 pmol/l; Po0.05, respectively). 4 The differences between normotensive and hypertensive subjects were consistent within agespecific groups as demonstrated in Figure 4 .
Although previous reports on the relationship between testosterone and blood pressure are conflicting, [20] [21] [22] [23] our study is supported by the results from the large Ranch Bernardo Study. 20 In addition, it is important to notice that no study has reported a positive association between endogenous testosterone and blood pressure or found higher levels of testosterone in hypertensive men. We therefore consider our results plausible.
Testosterone and glucose metabolism
Fasting glucose or insulin levels were not measured in the fourth Tromsø Study. However, glycosylated hemoglobin (HbA1c) was measured. Hyperglycemia, as measured by HbA1c, is related to CVD mortality. 24 HbA1c is also positively related to coronary heart disease and CVD mortality in men across the normal HbA1c range. 24 In Tromsø men, low testosterone levels were independently associated with higher HbA1c levels, and in age-and WC-adjusted analyses, HbA1c levels were significant higher in men in the lowest total testosterone quintile. Finally, men with diabetes had lower total testosterone levels (11.4 vs 13.1 nmol/l; Po0.05). 5 A large body of evidence supports the cross-sectional associations of lower total and free testosterone with impaired glucose tolerance and type II diabetes. 25 Lower levels of endogenous testosterone are also associated with increased insulin concentrations and insulin resistance in men. [26] [27] [28] [29] In addition, low levels of testosterone have been reported to predict insulin resistance and incident type II diabetes in older men prospectively. 30, 31 Associations between testosterone and the metabolic syndrome
In a cross-sectional study by Muller et al. 32 of 400 men between 40 and 80 years old from Utrecht, The Netherlands, low endogenous testosterone levels was independently associated with all separate components of the metabolic syndrome as well as the metabolic syndrome according to NCEP. Each s.d. (5.3 nmol/l) increase in total testosterone was associated with a 57% reduced risk of having the metabolic syndrome.
Low testosterone has also been shown to predict the development of the metabolic syndrome. 33, 34 In the Kuopio Ichemic Hearth Disease Risk Factor Study men with a concentration of total testosterone in the lower quartile were twofold more likely to develop the metabolic syndrome compared to the other men during the 11-year follow-up, independent of potential confounders, such as coronary artery disease, smoking, alcohol consumption and socioeconomic status. 33 Similar results were recently published from the Massachusetts Male Aging Study. 34 Among non-overweight men, testosterone levels in the lower quartile compared with the highest quartile showed a twofold increase in the risk of developing the metabolic syndrome. Again, these relationships were independent of age, smoking, self-reported overall health status and number of conditions defining the metabolic syndrome. Furthermore, there was no clear threshold effect, but a trend of increasing metabolic syndrome with lower testosterone levels.
In another interesting publication from the 'Kuopio study', Laaksonen et al. 35 looked at the inverse relation: the risk of developing hypogonadism in men with the metabolic syndrome. They found a threefold increase risk of developing hypogonadism at the 11-year follow-up in men having metabolic syndrome at baseline, using either the WHO or the NCEP definition. Thus, they suggest that the metabolic syndrome is not only a consequence of low testosterone levels but may also be a cause of hypogonadism.
Although this presentation is based mostly on large population-based studies, there are limitations. Firstly and most important, the results are mostly obtained from cross-sectional data and do not provide direct evidence of cause and effect. Although there are strong associations between lower testosterone levels and the components of the metabolic syndrome, which all are risk factors for CVD, so far no association has been found between endogenous testosterone levels and cardiovascular events. 36, 37 In summary, there are strong associations between low levels of testosterone and the different components of the metabolic syndrome. There is also an independent association between low testosterone levels and the metabolic syndrome itself in both cross-sectional and prospective population-based studies. Thus, testosterone may have a protective role in the development of metabolic syndrome and subsequent diabetes mellitus and CVD in aging men. However, clinical studies are needed to confirm these associations, and we are therefore currently conducing a follow-up study with focus on hypogonadism and the metabolic syndrome in older men who participated in the Tromsø Study. 
